Literature DB >> 15279782

H2AX: the histone guardian of the genome.

Oscar Fernandez-Capetillo1, Alicia Lee, Michel Nussenzweig, André Nussenzweig.   

Abstract

At close hand to one's genomic material are the histones that make up the nucleosome. Standing guard, one variant stays hidden doubling as one of the core histones. But, thanks to its prime positioning, a variation in the tail of H2AX enables rapid modification of the histone code in response to DNA damage. A role for H2AX phosphorylation has been demonstrated in DNA repair, cell cycle checkpoints, regulated gene recombination events, and tumor suppression. In this review, we summarize what we have learned about this marker of DNA breaks, and highlight some of the questions that remain to be elucidated about the physiological role of H2AX. We also suggest a model in which chromatin restructuring mediated by H2AX phosphorylation serves to concentrate DNA repair/signaling factors and/or tether DNA ends together, which could explain the pleotropic phenotypes observed in its absence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15279782     DOI: 10.1016/j.dnarep.2004.03.024

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  356 in total

1.  Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity.

Authors:  Robert J Kinders; Melinda Hollingshead; Scott Lawrence; Jiuping Ji; Brian Tabb; William M Bonner; Yves Pommier; Larry Rubinstein; Yvonne A Evrard; Ralph E Parchment; Joseph Tomaszewski; James H Doroshow
Journal:  Clin Cancer Res       Date:  2010-10-05       Impact factor: 12.531

2.  PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors.

Authors:  Brian McEllin; Cristel V Camacho; Bipasha Mukherjee; Brandon Hahm; Nozomi Tomimatsu; Robert M Bachoo; Sandeep Burma
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

3.  HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction.

Authors:  Eva Polanská; Zuzana Dobšáková; Martina Dvořáčková; Jiří Fajkus; Michal Štros
Journal:  Chromosoma       Date:  2012-04-28       Impact factor: 4.316

4.  Deregulation of DNA damage response pathway by intercellular contact.

Authors:  Meyke Ausman Kang; Eui-Young So; Toru Ouchi
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

5.  Modification of the DNA damage response by therapeutic CDK4/6 inhibition.

Authors:  Jeffry L Dean; A Kathleen McClendon; Erik S Knudsen
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

6.  Gelatin-based laser direct-write technique for the precise spatial patterning of cells.

Authors:  Nathan R Schiele; Douglas B Chrisey; David T Corr
Journal:  Tissue Eng Part C Methods       Date:  2010-10-27       Impact factor: 3.056

7.  Recruitment of DNA replication and damage response proteins to viral replication centers during infection with NS2 mutants of Minute Virus of Mice (MVM).

Authors:  Zandra Ruiz; Ivailo S Mihaylov; Susan F Cotmore; Peter Tattersall
Journal:  Virology       Date:  2010-12-30       Impact factor: 3.616

8.  Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.

Authors:  Madhav Sankunny; Rahul A Parikh; Dale W Lewis; William E Gooding; William S Saunders; Susanne M Gollin
Journal:  Genes Chromosomes Cancer       Date:  2013-11-25       Impact factor: 5.006

9.  Integrated signaling in developing lymphocytes: the role of DNA damage responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

Review 10.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Curr Opin Cell Biol       Date:  2009-02-21       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.